Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Endocrinology|June 19, 2012
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free intervalSalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.Plos One|March 26, 2015
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patientsEnke Baldini, Chiara Tuccilli, Natalie Prinzi, et al.International Journal of Molecular Sciences|April 12, 2022
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell LinesEnke Baldini, Dario Presutti, Pasqualino Favoriti, et al.Nutrition (Burbank, Los Angeles County, Calif.)|March 13, 2018
Iodine deficiency in pregnancy: Still a health issue for the women of Cassino city, ItalyChiara Tuccilli, Enke Baldini, Elia Truppa, et al.Cancers|December 9, 2020
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational StudySalvatore Sorrenti, Giovanni Carbotta, Filippo Maria Di Matteo, et al.Molecular and Cellular Endocrinology|January 17, 2017
Deregulated expression of VHL mRNA variants in papillary thyroid cancerEnke Baldini, Chiara Tuccilli, Yannick Arlot-Bonnemains, et al.Journal of Clinical Medicine|September 28, 2021
Expression and Clinical Utility of Transcription Factors Involved in Epithelial-Mesenchymal Transition during Thyroid Cancer ProgressionEnke Baldini, Chiara Tuccilli, Daniele Pironi, et al.Pageof 5